IncellvuS.A.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-01-23
Share capital
3 306 050,00 PLN
Activity description

Incellvu is a company that develops innovative devices for ultra-fast volumetric imaging of the cellular structure of the human retina in vivo. They aim to create an optical coherence tomography (OCT) system for non-invasive imaging of the eye's structure and function with microscopic resolution, supporting the diagnosis of eye diseases and gene therapies to prevent vision loss. Their technology, known as spatio-temporal optical coherence tomography (STOC-T), allows for high-resolution imaging and functional analysis of the retina.

Registered address
ul. Skierniewicka 10A, 01-230 Warszawa, Poland
Website
incellvu.plWebsite active
Social media
Electronic delivery address
AE:PL-26649-64477-HBFVG-23

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 6.99kMedianUSD 133.91kAverageUSD 4.65m
Net profit
This companyUSD -558.98kMedianUSD -54.78AverageUSD 310.10k
Operating costs
This companyUSD 564.59kMedianUSD 175.72kAverageUSD 4.46m
Assets
This companyUSD 1.69mMedianUSD 254.44kAverageUSD 8.12m

Bank accounts

Registered as a VAT taxpayer on 2020-08-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,582

Tenders

No recorded participation in tenders.

Authorized Representatives

Łukasz Waldemar Kornaszewski – President of the Management Board

Manner of representation

One member of the management board acting independently is authorized to make declarations of will and sign on behalf of the company.

Supervisory board

Adam Krzysztof Roślewski – Supervisory Board Member
Edward Aleksander Wylęgała – Supervisory Board Member
Dawid Mateusz Borycki – Supervisory Board Member
Jacek Witold Gregorowicz – Supervisory Board Member
Krzysztof Jassem – Supervisory Board Member

Beneficial owners

Person

Competitors

Name
Digital Pathology Teamsp. z o.o.
Luna Laboratorysp. z o.o.
Biostat Research And Developmentsp. z o.o.
Stenocoatsp. z o.o.
Medaisp. z o.o.
Muotechsp. z o.o.
InventroS.A.
Oncotherics PolandS.A.
Poltisssp. z o.o.

Change history

DateEvent
2025-07-10Share capital change
2025-02-25Address change
2025-02-25Share capital change
2025-02-24PKD change
2024-05-29Share capital change

FAQ

Last updated: 2026-07-02